IBDEI0QG ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13006,0)
 ;;=174.9^^78^810^8
 ;;^UTILITY(U,$J,358.3,13006,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13006,1,1,0)
 ;;=1^174.9
 ;;^UTILITY(U,$J,358.3,13006,1,2,0)
 ;;=2^BREAST CANCER-FEMALE
 ;;^UTILITY(U,$J,358.3,13006,2)
 ;;=^267202
 ;;^UTILITY(U,$J,358.3,13007,0)
 ;;=189.0^^78^810^50
 ;;^UTILITY(U,$J,358.3,13007,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13007,1,1,0)
 ;;=1^189.0
 ;;^UTILITY(U,$J,358.3,13007,1,2,0)
 ;;=2^RENAL CELL CANCER
 ;;^UTILITY(U,$J,358.3,13007,2)
 ;;=^73523
 ;;^UTILITY(U,$J,358.3,13008,0)
 ;;=149.0^^78^810^45
 ;;^UTILITY(U,$J,358.3,13008,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13008,1,1,0)
 ;;=1^149.0
 ;;^UTILITY(U,$J,358.3,13008,1,2,0)
 ;;=2^PHARYNGEAL CANCER
 ;;^UTILITY(U,$J,358.3,13008,2)
 ;;=^267051
 ;;^UTILITY(U,$J,358.3,13009,0)
 ;;=173.00^^78^810^23
 ;;^UTILITY(U,$J,358.3,13009,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13009,1,1,0)
 ;;=1^173.00
 ;;^UTILITY(U,$J,358.3,13009,1,2,0)
 ;;=2^LIP CANCER,SKIN NOS
 ;;^UTILITY(U,$J,358.3,13009,2)
 ;;=^340596
 ;;^UTILITY(U,$J,358.3,13010,0)
 ;;=199.1^^78^810^37
 ;;^UTILITY(U,$J,358.3,13010,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13010,1,1,0)
 ;;=1^199.1
 ;;^UTILITY(U,$J,358.3,13010,1,2,0)
 ;;=2^MALIGNANT NEOPLASM NOS
 ;;^UTILITY(U,$J,358.3,13010,2)
 ;;=^87705
 ;;^UTILITY(U,$J,358.3,13011,0)
 ;;=V66.7^^78^811^1
 ;;^UTILITY(U,$J,358.3,13011,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13011,1,1,0)
 ;;=1^V66.7
 ;;^UTILITY(U,$J,358.3,13011,1,2,0)
 ;;=2^Hospice/Palliative Care-USE w/ ea encounter
 ;;^UTILITY(U,$J,358.3,13011,2)
 ;;=^89209
 ;;^UTILITY(U,$J,358.3,13012,0)
 ;;=348.1^^78^812^1
 ;;^UTILITY(U,$J,358.3,13012,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13012,1,1,0)
 ;;=1^348.1
 ;;^UTILITY(U,$J,358.3,13012,1,2,0)
 ;;=2^ANOXIC BRAIN DAMAGE
 ;;^UTILITY(U,$J,358.3,13012,2)
 ;;=^7979
 ;;^UTILITY(U,$J,358.3,13013,0)
 ;;=348.5^^78^812^2
 ;;^UTILITY(U,$J,358.3,13013,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13013,1,1,0)
 ;;=1^348.5
 ;;^UTILITY(U,$J,358.3,13013,1,2,0)
 ;;=2^CEREBRAL EDEMA
 ;;^UTILITY(U,$J,358.3,13013,2)
 ;;=^16710
 ;;^UTILITY(U,$J,358.3,13014,0)
 ;;=348.4^^78^812^3
 ;;^UTILITY(U,$J,358.3,13014,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13014,1,1,0)
 ;;=1^348.4
 ;;^UTILITY(U,$J,358.3,13014,1,2,0)
 ;;=2^COMPRESSION OF BRAIN
 ;;^UTILITY(U,$J,358.3,13014,2)
 ;;=^27114
 ;;^UTILITY(U,$J,358.3,13015,0)
 ;;=291.1^^78^812^7
 ;;^UTILITY(U,$J,358.3,13015,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13015,1,1,0)
 ;;=1^291.1
 ;;^UTILITY(U,$J,358.3,13015,1,2,0)
 ;;=2^DEMENTIA,ALCOHOL-INDUCED
 ;;^UTILITY(U,$J,358.3,13015,2)
 ;;=^331823
 ;;^UTILITY(U,$J,358.3,13016,0)
 ;;=331.0^^78^812^8
 ;;^UTILITY(U,$J,358.3,13016,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13016,1,1,0)
 ;;=1^331.0
 ;;^UTILITY(U,$J,358.3,13016,1,2,0)
 ;;=2^DEMENTIA,ALZHEIMER'S DISEASE
 ;;^UTILITY(U,$J,358.3,13016,2)
 ;;=^5679
 ;;^UTILITY(U,$J,358.3,13017,0)
 ;;=292.82^^78^812^9
 ;;^UTILITY(U,$J,358.3,13017,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13017,1,1,0)
 ;;=1^292.82
 ;;^UTILITY(U,$J,358.3,13017,1,2,0)
 ;;=2^DEMENTIA,DRUG-INDUCED
 ;;^UTILITY(U,$J,358.3,13017,2)
 ;;=^331832
 ;;^UTILITY(U,$J,358.3,13018,0)
 ;;=290.40^^78^812^10
 ;;^UTILITY(U,$J,358.3,13018,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13018,1,1,0)
 ;;=1^290.40
 ;;^UTILITY(U,$J,358.3,13018,1,2,0)
 ;;=2^DEMENTIA,VASCULAR
 ;;^UTILITY(U,$J,358.3,13018,2)
 ;;=^10350
 ;;^UTILITY(U,$J,358.3,13019,0)
 ;;=341.9^^78^812^11
 ;;^UTILITY(U,$J,358.3,13019,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13019,1,1,0)
 ;;=1^341.9
 ;;^UTILITY(U,$J,358.3,13019,1,2,0)
 ;;=2^DEMYELINATING DIS O/T MS
